The possibility of erasing high cholesterol with a single gene-editing infusion now looms over medicine, threatening to upend decades of statin dependence and redefine what “lifelong treatment” means. Quick Take First-ever human trial shows CRISPR therapy can halve LDL cholesterol and triglycerides within weeks No serious adverse events reported, raising